Skip to Content

20/12.5 Logo 5034 (Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg)

Pill with imprint 20/12.5 Logo 5034 is Yellow, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 20/12.5 Logo 5034

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034

Hydrochlorothiazide and Lisinopril

Imprint
20/12.5 Logo 5034
Strength
12.5 mg / 20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Ace inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
calcium phosphate dibasic anhydrous, magnesium stearate, mannitol, corn starch, magnesium silicate, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00172-5034 Ivax Pharmaceuticals, Inc.
43063-0065 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.